Sio Gene Therapies Stock Predictions

Healthcare > Biotechnology

Buy SIOX

*Your capital is at risk

$0.478

+0 (+0%)

At Close: May 06, 2024

Currently predicting for Mon, 8 Jun 2026

SIOX Prediction Chart

SIOX Predictions History

Latest community submissions for SIOX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Feb 26, 2021	$2.71 +2.65%	$2.64	X	97.35%	0
DonutFarmer	Feb 26, 2021	Bearish	$2.64	X	—	1
JS Pro	Jan 7, 2021	$3.00 -3.85%	$3.12	X	96.15%	0
Baltzera Merchant	Jan 7, 2021	Bullish	$3.12	X	—	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SIOX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT SIO GENE THERAPIES INC

Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-G...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	4.09%	May 06
GLBE $31.61	1.65%	May 05
SAP $172.39	7.18%	May 05
FIZZ $34.11	7.04%	May 01
ADBE $243.57	3.23%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by